Nomura Holdings’s Tectonic Therapeutic TECX Stock Holding History

Nomura Holdings’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,407	Closed	-$296K	–	2488
2021 Q4	$296K	Buy	+6,407	New	+$368K	﹤0.01%	1680

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's TECX Position: Q1 2022 in Review

Nomura Holdings sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 6,407 shares — an estimated $296K sold.

Nomura Holdings first reported a position in TECX in Q4 2021 and held it in 1 quarter. The position peaked at $296K in Q4 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

Nomura Holdings reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 6,407 Tectonic Therapeutic shares in Q1 2022, an estimated $296K.
Nomura Holdings first reported a position in Tectonic Therapeutic in Q4 2021 and held it in 1 quarter.
Nomura Holdings's Tectonic Therapeutic position peaked at $296K in Q4 2021.
79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.